CClinicalTrials.gg
RecruitingNCT05737823Updated Jun 23, 2023

Supporting Family Carers' Mental Health

An interventional study of Carers-ID online support programme and Carers-ID online support programme - Wait-list control in Feasibility, sponsored by Queen's University, Belfast. Recruiting at 1 site in United Kingdom. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-06-23.

Sponsored by Queen's University, Belfast · Not applicable, Interventional, and Supportive care

From the registry’s dates

  • Primary completion was expected by Jul 2024, 2 years 2 months ago, but the record still lists the study as recruiting.
  • Started May 2023; still recruiting 3 years 4 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

Brief Summary:

Background: Feasibility and acceptability of the Carers-ID intervention to improve mental health outcomes in family carers of people with intellectual disabilities.

Objective:

  1. To conduct a Phase II feasibility randomised controlled trial and process evaluation of the Carers-ID programme.
  2. To determine the acceptability of outcome measures of stress, anxiety, depression, resilience and well-being in assessing the impact of the programme on family carers.
  3. To determine the recruitment and retention rates of participants in the trial.
  4. To identify potential effect sizes and estimate appropriate sample size for use in an effectiveness trial.
  5. To determine if progression to a phase III effectiveness trial is warranted.

Methodology:

Family carers (n = 120) will be randomised to receive the programme (n=60) or assigned to a wait-list control (n=60) group. The intervention (Carers-ID) consists of ten modules which cover topics including: promoting resilience, reducing anxiety, managing stress, accessing local supports, managing family conflict and information for siblings who are carers. Participants (n=12) who have taken part in the intervention arm of the research will be invited to participate in the process evaluation.

Outcome:

  1. Retention of Subjects in Study Assessments (>80% of family carers)
  2. Recruitment of Subjects into Study (>90 carers)
  3. Acceptability and feasibility of the outcome measures (>80% of family carers)
  4. Depression, Anxiety and Stress Scale - 21; The Warwick-Edinburgh Mental Well-being Scale; The Resilience Scale; and The Social Connectedness Scale Revised.

Number of participants to be enrolled: 120 family carers

Main inclusion criteria: Participants will be UK adults >18 years of age and will be caring for a family member with an intellectual disability.

Statistical Analysis: Descriptive statistics will be used to summarise baseline data including demographic variables and questionnaire responses. Inferential statistics (t-tests or ANOVA) will be used as indicators of difference between the intervention and control arms and will be used to determine effect sizes for sample size calculation in a future phase III trial.

Study duration: 24 months

02

Conditions studied

  • Feasibility

Keywords

  • Family carer
  • Intellectual disabilities
  • Feasibility
  • Mental health
  • Intervention
03

In context

Lead sponsor

Queen's University, Belfast is the lead sponsor of 113 studies on the registry; 14 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria:

  • Resident of the UK;
  • >18 years of age;
  • Caring for a family member with an intellectual disability.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Care provider, Outcomes assessor)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    Carers-ID online support programme

    Participants in this arm will receive access to the Carers-ID online programme. Participants will be able to access the online programme for 2 weeks.

    Behavioral: Carers-ID online support programme

  • Other
    Wait-list Control

    Wait-list control arm

    Behavioral: Carers-ID online support programme - Wait-list control

Interventions

  • BehavioralCarers-ID online support programme

    The Carers-ID online programme, which consists of ten modules which cover topics including: promoting resilience, reducing anxiety, managing stress, accessing local supports, managing family conflict and information for siblings who are carers.

  • BehavioralCarers-ID online support programme - Wait-list control

    The same programme as above delivered to the wait-list control after the T2 follow-up data has been collected.

06

What researchers measure

Primary outcomes

  1. Retention of Subjects in Study Assessments

    Retain 80% of intervention and control participants

    Time frame: 3 months

  2. Recruitment of Subjects Into Study

    Sufficient recruitment is set as \>90 family carers.

    Time frame: 3 months

  3. Acceptability and feasibility of the outcome measures

    Acceptability and feasibility of the outcome measures determined by process evaluation (\>80% of family carers).

    Time frame: 6 months

Secondary outcomes

  1. Depression, Anxiety and Stress Scale - 21 (DASS-21)

    The Depression, Anxiety and Stress Scale - 21 Items (DASS-21) is a set of three self-report scales designed to measure the emotional states of depression, anxiety and stress. Each of the three DASS-21 scales contains 7 items, with 21 items in total. Items are rated on a 4 point Likert scale, from 'Did not apply to me at all' to 'Applied to me very much or most of the time'. Scores for depression, anxiety and stress are calculated by summing the scores for the relevant items and multiplying by 2, with potential scores ranging from 0 to a maximum of 42. With higher scores indicating increased severity of emotional state.

    Time frame: Baseline (T0), 2 weeks (T1), 3 months (T2)

  2. The Warwick-Edinburgh Mental Well-being Scale (WEMWBS)

    The Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS) was developed to enable the measurement of mental wellbeing. The WEMWBS is a 14-item scale of positively worded statements covering feeling and functioning aspects of mental wellbeing. The 14-statements have five response categories from 'none of the time' to 'all of the time'. The WEMWBS is scored by summing the scores for each of the 14 items, which are scored from 1 to 5. Scores range from 14 to 70 and higher scores indicate greater positive mental wellbeing.

    Time frame: Baseline (T0), 2 weeks (T1), 3 months (T2)

  3. The Resilience Scale (RS-25)

    The 25 Item Resilience Scale was developed as a general measure of resilience for adults across the lifespan. Participants respond by either agreeing or disagreeing with the statements on a scale of 1(disagree) to 7 (agree). The responses are summed (min 25 to max 175) and a higher score reflects stronger resilience.

    Time frame: Baseline (T0), 2 weeks (T1), 3 months (T2)

  4. The Social Connectedness Scale Revised

    This 20-item scale is used to assess the extent to which persons feel connected to others in their surrounding social area. It is on a Likert scale with 1 being strongly disagree to 6 being strongly agree. The negatively worded items are reverse scored and summed together with the positively worded items to create a scale score with a possible range from 20 to 120. An item mean score with a possible range from 1 to 6 can also be calculated by dividing the total scale score by 20 (or the number of scale items). Higher scores on the SCS-R reflect a stronger sense of social connectedness.

    Time frame: Baseline (T0), 2 weeks (T1), 3 months (T2)

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: Yes — All collected IPD will be made available in publications and open access databases.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jun 23, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05737823
Lead sponsor
Queen's University, Belfast
Collaborators
Baily Thomas Charitable Fund, University of Glasgow, University of Sheffield, University of South Wales
Responsible party
Dr Mark Linden (Reader, Queen's University, Belfast) — Principal investigator
First posted
Feb 21, 2023
Start date
May 12, 2023
Primary completion
Jul 30, 2024 (estimated)
Completion
Mar 30, 2025 (estimated)
Last update
Jun 23, 2023

Study contacts

Mark Linden, PhD
Contact
m.linden@qub.ac.uk
028 9097 2233
Rachel Leonard, PhD
Contact
rachel.leonard@qub.ac.uk

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion